You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大和:料線上藥物銷售增長將明顯跑贏同業,上調平安好醫生(1833.HK)目標價至117港元,評級“跑贏大市”
格隆匯 03-08 10:19
格隆匯3月8日丨大和發研報指,平安好醫生管理層更新對未來數年的策略,相信當中策略升級和集團的協同渠道需關注。至去年底,公司新增超過1100企業客户,銷售達5.8億元人民幣。集團已擁有超過100萬企業客户。互聯網醫院不單是一次性的線上醫療服務,同時亦有助公司吸納客户,並交叉銷售產品。該行重申對公司主要競爭優勢,包括大量客户流量、AI強勁、壟斷地位等,故預期線上藥物銷售增長會明顯跑贏其他同業,而藥物名冊藥物的增長,以及線上醫院的增長都對公司非常有利,雖然線上醫療服務收入較健康商場少,但毛利貢獻增至47%,相對健康商場只有14%。該行重申對平安好醫生“跑贏大市”評級,目標價由100港元上調至117港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account